# Fairchem Organics share price today (Fairchem Organics Ltd, NSE: FAIRCHEMOR)

> Fairchem Organics share price today: ₹681.45 at the NSE close on 4 November 2026, down 7.7% in a year. Fairchem Organics (NSE: FAIRCHEMOR) is worth ₹858 crore, trades at a P/E of 35.0 and has closed between ₹457.30 and ₹797.10 over the past 52 weeks. > Fairchem Organics Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. FAIRCHEMOR · Chemicals - Organic · data as of 4 November 2026. Page: https://www.sectoralpha.in/stocks/fairchem-organics-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting better, from the last 12 quarters
- Price: ₹681.45 (−7.7% in a year)
- P/E: 35.0× (lower than 62% of the last 5.8 years)
- Revenue (Sep 2026): ₹167 Cr (+49.1% on a year ago)
- Profit (Sep 2026): ₹10.0 Cr (+900.0% on a year ago)
- Operating margin: 10.0% (+6.2 points on a year ago)
- ROCE: 3%, FY26
- ROIC: 7.8%, against a 12.0% cost of capital: −4.2 points

The main question: the share price moved −7.7% in a year while yearly earnings per share moved −73.9%. The difference came from the market paying a higher multiple. ## What is the Fairchem Organics share price today? Fairchem Organics Ltd's share price was ₹681.45 at the close on 4 November 2026. It has been stalling near its high for 4 weeks. That is 0.6% below its average price over the last 200 trading days. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 2 weeks running. In the last 52 weeks it traded between ₹457 and ₹797, and at that close it sat 66% of the way up from that low. Over the last 5.9 years the share price moved +5% while the NIFTY 500 moved +90%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 23 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Fairchem Organics this quarter? 2 points on a year earlier. 1. Indian funds and insurers (DIIs) cut their stake for 5 quarters in a row From 5.8% to 1.4% of the company by the September 2026 quarter. 2. Operating margin up 6.2 points on a year earlier 10% in the September 2026 quarter, from 3.8%. Why: Margins rose because raw materials cost less and the company sold finished products at higher prices. Next results: check whether margins hold, since management said it is confident to maintain them if conditions stay as they have been over the last 6 months. From the earnings call on 23 Oct 2026. ## What are Fairchem Organics' latest quarterly results? For July to September 2026 (the quarter ended 30 September 2026), Fairchem Organics reported revenue of ₹167 crore, up 49.1% from ₹112 crore a year earlier, and a profit of ₹10.0 crore, up 900.0% from ₹1.00 crore. ### Fairchem Organics results: July to September 2026 against a year earlier

| Measure | July to September 2026 | July to September 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹167 crore | ₹112 crore | +49.1% |
| Profit | ₹10.0 crore | ₹1.00 crore | +900.0% |
| Earnings per share | ₹8.07 | ₹0.59 | +1,267.8% |
| Operating margin | 10.0% | 3.8% | +6.2 points |

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). Fairchem Organics' management discussed these results on a call held on 23 October 2026; what it said is further down this page. (From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.)

## What is the Fairchem Organics share price history? Fairchem Organics closed at ₹681.45 on 4 November 2026, down 7.7% from ₹738.45 a year earlier (7 November 2025) and down 65.7% over five years. Its highest weekly close since December 2020 was ₹2,217.00 on 14 October 2022. ### Fairchem Organics share price: then and now

| When | Close | Change to 4 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 30 Oct 2026 | ₹636.15 | +7.1% |
| 1 month ago · 1 Oct 2026 | ₹661.50 | +3.0% |
| 6 months ago · 8 May 2026 | ₹619.40 | +10.0% |
| 1 year ago · 7 Nov 2025 | ₹738.45 | −7.7% |
| 3 years ago · 3 Nov 2023 | ₹1,132.45 | −39.8% |
| 5 years ago · 4 Nov 2021 | ₹1,986.85 | −65.7% |
| Earliest weekly close in our records · 24 Dec 2020 | ₹650.65 | +4.7% |
| Highest weekly close since December 2020 · 14 Oct 2022 | ₹2,217.00 | −69.3% |
| Lowest weekly close since December 2020, also the 52-week low · 27 Mar 2026 | ₹457.30 | +49.0% |
| 52-week high (weekly close) · 31 Jul 2026 | ₹797.10 | −14.5% |

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (313 weekly closes from 24 December 2020 to 4 November 2026.)

## What is the latest news on Fairchem Organics? 4 Nov 2026: Fairchem Organics closed at ₹681.45, up 7.1% on the week and up 3.0% on the month. 23 Oct 2026: Fairchem Organics held its results call for July to September 2026. Management guided: Current operating margin to be maintained, with further improvement pursued. ### Earlier

- Results for July to September 2026: Revenue up 49.1% and profit up 900.0% on a year earlier. - 20 Jul 2026: ex-date for a dividend of ₹1 a share. ## What dividend does Fairchem Organics pay? Fairchem Organics paid ₹1 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 0.15% at the ₹681.45 close on 4 November 2026. The last was a dividend of ₹1 a share, ex-date 20 July 2026. ### Fairchem Organics dividends since 1 April 2021

| Ex-date | Dividend per share | Type |
| --- | --- | --- |
| 20 Jul 2026 | ₹1 | Dividend |
| 4 Aug 2025 | ₹7.50 | Dividend |
| 29 Jul 2024 | ₹7.50 | Dividend |
| 31 Jul 2023 | ₹7.50 | Dividend |
| 28 Jul 2022 | ₹13 | Dividend |
| 17 Aug 2021 | ₹3.50 | Dividend |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here. 5 of 5 Of the last 5 financial years, years with an NSE dividend record

Not in its latest year. Fairchem Organics Ltd paid out 0% of its profit as dividends in FY26. It did pay a dividend in 5 of its last 7 reported years, so there is a history but no current dividend. (From the NSE corporate-actions record, read 5 November 2026.)

## What did Fairchem Organics management say on the latest results call? > “We are confident that we will be able to maintain this if the situation remains as it has been over the last 6 months.”
> Nahoosh Jariwala, Managing Director and Chairman, on the call for July to September 2026

### What management guided

- Business growth of 5-10% each quarter. - Capacity utilization to improve by 5% each quarter. - Novel fatty-acid pilot expected to start operations in Oct-Dec, after Diwali. - US exports expected to commence once freight stabilizes. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijorifinance.com/insight/india/40795/Conference Call/CC-Oct26.pdf). (From the call for July to September 2026, 23 October 2026.)

## What to watch in Fairchem Organics' next results? First: Sequential tonnage: check whether production growth resumes against the stated quarterly ramp. - What to check (from the call)
- Sequential tonnage: check whether production growth resumes against the stated quarterly ramp. - Novel fatty-acid pilot: verify commissioning after R&D modifications and identify any initial operating hiccups. - Soybean-oil availability and input-price softening: check whether feedstock relief appears in utilization and margins. - US export shipments: monitor whether freight stabilizes enough to convert completed groundwork into dispatches. ## Which stock lists is Fairchem Organics on? Fairchem Organics is not on any of our India lists this week. ## Is Fairchem Organics profitable? Fairchem Organics Ltd earned ₹10.0 Cr of net profit in the Sep 2026 quarter, +900.0% on the same quarter a year earlier. That is the 3rd quarter in a row of profit growth. Full-year FY26 profit was ₹6.0 Cr. Over 6 years profit has grown −25.5% a year on average. That is 6.0% of the quarter's revenue. The same quarter a year earlier earned ₹1.0 Cr. For the full year, FY26 profit was ₹6.0 Cr (−72.7% on the year before). Why profit moved: revenue changed +49.1% on a year earlier and the margin moved +6.2 percentage points. Most of the change came from keeping more of each sale. On average over the last four quarters, profit changed +500.0% and revenue +17.0%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit. ## How much revenue does Fairchem Organics make, and is it growing? Fairchem Organics Ltd reported ₹167 Cr of revenue in the Sep 2026 quarter, +49.1% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 6 years it has grown 7.0% a year on average. The last full year, FY26, came in at ₹460 Cr. The last four reported quarters add to ₹560 Cr. FY26 revenue was ₹460 Cr, −14.5% on the year before. Recent pace: the last four quarters grew +17.0% on average, against 7.0% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +17.2%, against −4.4% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +242.9%, against −24.4% a year (accelerating). ## How much of every ₹100 of sales does Fairchem Organics keep? Fairchem Organics Ltd's operating margin was 10.0% in the Sep 2026 quarter, 6.2 percentage points higher than the same quarter a year ago. Across 7 years it has been between 4.7% and 17.0%. The latest quarter is within that range. Why the margin moved: operating margin changed +6.7 percentage points on the year while gross margin changed +4.2 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Fairchem Organics' profit turning into cash? Over the last 3 years, 146% of Fairchem Organics Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹42.0 Cr of operating cash against ₹6.0 Cr of profit. After ₹12.0 Cr of spending on assets, ₹30.0 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 146% of profit came in as cash: the cash cycle got 48 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. What to look at next: the bigger use of cash is spending on new assets, at 1.7× depreciation over three years. The next section checks what that spending is building. ## Where does Fairchem Organics' cash go? Fairchem Organics Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 139 days in FY26, up from 91 days in FY21. It spent ₹54.0 Cr on assets over the last 3 years. Customers take 54 days to pay, and stock sits for 96 days on average. At FY26 sales of ₹460 Cr, each day of that cycle ties up about ₹1.3 Cr, so roughly ₹175 Cr is tied up in the business at any time. FY26: customers took 54 days to pay and stock sat for 96 days, about 3.2 months of sales sitting as stock, for a full cycle of 139 days, longer than FY21's 91. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 96 days. Customers pay about 54 days after that. Suppliers are paid at 12 days. Together that makes the 139-day cycle. Spending on assets: ₹54.0 Cr over the last 3 years, against ₹31.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹18.0 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Fairchem Organics' P/E ratio, and how does it compare with its own history? Fairchem Organics Ltd's P/E is 35.0×, in the middle of its own history: higher than 38% of past readings. Its usual P/E (the middle reading) is 38.1×, over 5.8 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Sep 2026 add up to ₹18.87. Why the multiple is where it is: over the past year earnings per share moved −73.9% while the price moved −7.7%. The price did better than earnings, which pushed the multiple up within its own range. Where the price move came from: over 5 years the price moved −19.3% a year; about −19.6% a year came from earnings growth and about +0.3 percentage points from the multiple (roughly no change). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Fairchem Organics business getting better or worse? Fairchem Organics Ltd's business is getting better. EPS growth hit its low 3 quarters ago at −85.6% and has recovered to +306.7%, with ROCE steady at 3.9%. This is based on 12 quarters of 4 measures. Why it matters: a lasting rise from a low is what this page is built to show. The latest quarter’s profit includes a one-off item bigger than the normal business, so the profit line is shown but does not count in this reading. ## How much does Fairchem Organics earn on its capital? Fairchem Organics Ltd earned a ROCE of 3% in FY26. Its return on capital used (ROIC) is 4.2 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 1.3% net margin and 1.18× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 1.3% net margin × 1.18× asset turnover × 1.49× leverage (assets divided by equity) ≈ 2.3% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 7.8% − 12.0% = −4.2 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The 7.8% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 2.3%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Fairchem Organics have too much debt? Fairchem Organics Ltd has total debt of ₹70.0 Cr against shareholder equity of ₹282 Cr as of Sep 2026, so its debt is 0.25× its equity, which is very little. Year by year, that ratio went from 0.27 in FY22 to 0.32 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Fairchem Organics shareholding pattern? Domestic institutions cut their stake in Fairchem Organics Ltd by 3.7 percentage points over 8 quarters, the biggest change among its owners. Domestic institutions now own 1.4% of the company. Promoters moved +2.0 points over the same period, to 63.3%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Domestic institutions: −3.7 points over 8 quarters, to 1.4%; Promoters: +2.0 points over 8 quarters, to 63.3%; Foreign institutions: +0.1 points over 8 quarters, to 6.4%. Why the owners changed: domestic institutions drove it (−3.7 points), with the other side taken by promoters (+2.0 points). They reduced their stake. ## How far is Fairchem Organics from balance-sheet trouble? For Fairchem Organics Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Fairchem Organics rank in its industry? 53.3 out of 100, rank 10 of 20 in Chemicals - Organic, with 100% of the evidence available. Fairchem Organics Ltd scores 53.3 out of 100 against the 20 companies it is compared with in Chemicals - Organic, ranking 10. Earnings are strong; relative strength in its sector is -15.4% and the one-year return is -15.9%. The four parts add up to the total exactly: 30.3 + 7 + 13 + 3 = 53.3. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Fairchem Organics compared with? Fairchem Organics ranks 10 of 20 Chemicals - Organic companies on the 4-Factor Sector Score, with 53.3 out of 100. 1. [Nitta Gelatin India Ltd](https://www.sectoralpha.in/stocks/nitta-gelatin-india-ltd) NITTAGELA · quiet · Most evidence points up · 85% evidence 76.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.4/35 · Revenue 15% · Profit 49.4% · Operating margin change 9 points · 100% evidence Capital efficiency 21.3/25 · ROCE 27.7% · Operating margin 28% · 100% evidence Valuation 13.2/20 · P/E 12.1× · PEG 0.95 · 100% evidence Relative strength 12.0/20 · Lead over its industry n/a · Lead over NIFTY 500 35.5% · 1 year n/a · 25% evidence · 5 of 12 weeks ahead Exact sum: 30.4 + 21.3 + 13.2 + 12 = 76.9 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Indo Amines Ltd](https://www.sectoralpha.in/stocks/indo-amines-ltd) INDOAMIN · losing its lead · Most evidence points up · 81% evidence 66.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.8/35 · Revenue 13.3% · Profit 24.2% · Operating margin change 3 points · 88% evidence Capital efficiency 16.8/25 · ROCE 18.9% · Operating margin 14% · 100% evidence Valuation 19.0/20 · P/E 10.6× · PEG 0.32 · 100% evidence Relative strength 9.5/20 · Lead over its industry n/a · Lead over NIFTY 500 2.3% · 1 year -10.4% · 25% evidence · 4 of 12 weeks ahead Exact sum: 20.8 + 16.8 + 19 + 9.5 = 66.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Valiant Organics Ltd](https://www.sectoralpha.in/stocks/valiant-organics-ltd) VALIANTORG · breaking out · Evidence leans up · 78% evidence 61.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.4/35 · Revenue 1.5% · Profit 100% · Operating margin change 6 points · 83% evidence Capital efficiency 9.0/25 · ROCE 5.5% · Operating margin 18% · 76% evidence Valuation 10.9/20 · P/E 23.2× · PEG n/a · 50% evidence Relative strength 19.8/20 · Lead over its industry 24.1% · Lead over NIFTY 500 48.6% · 1 year 39.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 21.4 + 9 + 10.9 + 19.8 = 61.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [OCCL Ltd](https://www.sectoralpha.in/stocks/occl-ltd) OCCLLTD · breaking out · Too little evidence to rank firmly · 56% evidence 59.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 40.6% · Profit 100% · Operating margin change 7 points · 83% evidence Capital efficiency 12.3/25 · ROCE 13% · Operating margin 28% · 76% evidence Valuation 11.1/20 · P/E 11× · PEG n/a · 15% evidence Relative strength 12.1/20 · Lead over its industry n/a · Lead over NIFTY 500 45.3% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 23.6 + 12.3 + 11.1 + 12.1 = 59.1 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 5. [BASF India Ltd](https://www.sectoralpha.in/stocks/basf-india-ltd) BASF · quiet · Evidence leans up · 71% evidence 57.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.8/35 · Revenue 6.5% · Profit 62.4% · Operating margin change 4 points · 88% evidence Capital efficiency 11.7/25 · ROCE 14.5% · Operating margin 10% · 100% evidence Valuation 14.1/20 · P/E 21.4× · PEG n/a · 50% evidence Relative strength 7.7/20 · Lead over its industry n/a · Lead over NIFTY 500 -13% · 1 year -30.9% · 25% evidence · 5 of 12 weeks ahead Exact sum: 23.8 + 11.7 + 14.1 + 7.7 = 57.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Elantas Beck India Ltd](https://www.sectoralpha.in/stocks/elantas-beck-india-ltd) ELANTAS · leader · Evidence leans up · 67% evidence 57.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.7/35 · Revenue 18.7% · Profit 35.5% · Operating margin change 1 points · 95% evidence Capital efficiency 18.1/25 · ROCE 21.2% · Operating margin 23% · 76% evidence Valuation 6.5/20 · P/E 54.1× · PEG n/a · 50% evidence Relative strength 11.8/20 · Lead over its industry n/a · Lead over NIFTY 500 31.9% · 1 year 33.1% · 25% evidence · 12 of 12 weeks ahead Exact sum: 20.7 + 18.1 + 6.5 + 11.8 = 57.1 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 7. [Fine Organic Industries Ltd](https://www.sectoralpha.in/stocks/fine-organic-industries-ltd) FINEORG · leader · Evidence leans up · 96% evidence 56.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.9/35 · Revenue 7.1% · Profit 5.8% · Operating margin change 4 points · 88% evidence Capital efficiency 17.8/25 · ROCE 21.5% · Operating margin 25% · 100% evidence Valuation 15.0/20 · P/E 35.3× · PEG 0.58 · 100% evidence Relative strength 9.9/20 · Lead over its industry -7.6% · Lead over NIFTY 500 12.4% · 1 year 13.8% · 100% evidence · 9 of 12 weeks ahead Exact sum: 13.9 + 17.8 + 15 + 9.9 = 56.6 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 8. [Laxmi Organic Industries Ltd](https://www.sectoralpha.in/stocks/laxmi-organic-industries-ltd) LXCHEM · quiet · Evidence leans up · 81% evidence 54.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.1/35 · Revenue 5.5% · Profit 26% · Operating margin change 7.6 points · 88% evidence Capital efficiency 10.8/25 · ROCE 4.7% · Operating margin 12% · 100% evidence Valuation 13.1/20 · P/E 33.8× · PEG 1.14 · 100% evidence Relative strength 9.2/20 · Lead over its industry n/a · Lead over NIFTY 500 1.8% · 1 year -22% · 25% evidence · 10 of 12 weeks ahead Exact sum: 21.1 + 10.8 + 13.1 + 9.2 = 54.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Balaji Amines Ltd](https://www.sectoralpha.in/stocks/balaji-amines-ltd) BALAMINES · quiet · Evidence leans up · 78% evidence 53.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.2/35 · Revenue 11.1% · Profit 41.6% · Operating margin change 10 points · 83% evidence Capital efficiency 13.1/25 · ROCE 11% · Operating margin 25% · 76% evidence Valuation 9.1/20 · P/E 28× · PEG n/a · 50% evidence Relative strength 8.2/20 · Lead over its industry -2.5% · Lead over NIFTY 500 15.2% · 1 year 25.3% · 100% evidence · 6 of 12 weeks ahead Exact sum: 23.2 + 13.1 + 9.1 + 8.2 = 53.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. Fairchem Organics Ltd this page FAIRCHEMOR · quiet · Evidence leans up · 100% evidence 53.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.3/35 · Revenue 17.1% · Profit 100% · Operating margin change 6.2 points · 100% evidence Capital efficiency 7.0/25 · ROCE 3.3% · Operating margin 10% · 100% evidence Valuation 13.0/20 · P/E 32.7× · PEG 0.84 · 100% evidence Relative strength 3.0/20 · Lead over its industry -15.4% · Lead over NIFTY 500 3.2% · 1 year -15.9% · 100% evidence · 9 of 12 weeks ahead Exact sum: 30.3 + 7 + 13 + 3 = 53.3 · What this means: Earnings are strong; relative strength in its sector is -15.4% and the one-year return is -15.9%. 11. [Sigachi Industries Ltd](https://www.sectoralpha.in/stocks/sigachi-industries-ltd) SIGACHI · breaking out · Evidence leans down · 100% evidence 49.4 out of 100 Growth Capital Valuation Relative
12. [GFL Ltd](https://www.sectoralpha.in/stocks/gfl-ltd) GFLLIMITED · breaking out · Evidence leans down · 71% evidence 48.6 out of 100 Growth Capital Valuation Relative
13. [Jyoti Resins and Adhesives Ltd](https://www.sectoralpha.in/stocks/jyoti-resins-and-adhesives-ltd) JYOTIRES · basing · Evidence leans down · 74% evidence 43.7 out of 100 Growth Capital Valuation Relative
14. [Foseco India Ltd](https://www.sectoralpha.in/stocks/foseco-india-ltd) FOSECOIND · leader · Evidence leans down · 81% evidence 41.1 out of 100 Growth Capital Valuation Relative
15. [Shree Ganesh Remedies Ltd](https://www.sectoralpha.in/stocks/shree-ganesh-remedies-ltd) SGRL · breaking out · Evidence leans down · 85% evidence 40.3 out of 100 Growth Capital Valuation Relative
16. [Oriental Aromatics Ltd](https://www.sectoralpha.in/stocks/oriental-aromatics-ltd) OAL · leader · Evidence leans down · 74% evidence 36.5 out of 100 Growth Capital Valuation Relative
17. [Gem Aromatics Ltd](https://www.sectoralpha.in/stocks/gem-aromatics-ltd) GEMAROMA · quiet · Too little evidence to rank firmly · 51% evidence 32.2 out of 100 Growth Capital Valuation Relative
18. [Sacheerome Ltd](https://www.sectoralpha.in/stocks/sacheerome-ltd) SACHEEROME · losing its lead · Too little evidence to rank firmly · 36% evidence 58.1 out of 100 Growth Capital Valuation Relative
19. [Shri Ahimsa Naturals Ltd](https://www.sectoralpha.in/stocks/shri-ahimsa-naturals-ltd) SHRIAHIMSA · leader · Too little evidence to rank firmly · 47% evidence 56.8 out of 100 Growth Capital Valuation Relative
20. [Citurgia Biochemicals Ltd](https://www.sectoralpha.in/stocks/citurgia-biochemicals-ltd) CITURGIA · Too little evidence to rank firmly · 25% evidence 34.3 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Chemicals - Organic](https://www.sectoralpha.in/sectors/chemicals-organic), all 20 compared on one page. ## Which companies are close to Fairchem Organics in size? Fairchem Organics is the 17th largest of 20 Chemicals - Organic companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Indo Amines, Valiant Organics and OCCL. Just below it: Shree Ganesh Remedies, Gem Aromatics and GFL. ### Chemicals - Organic companies close in size

1. [Indo Amines Ltd](https://www.sectoralpha.in/stocks/indo-amines-ltd) ₹865 crore
2. [Valiant Organics Ltd](https://www.sectoralpha.in/stocks/valiant-organics-ltd) ₹864 crore
3. [OCCL Ltd](https://www.sectoralpha.in/stocks/occl-ltd) ₹841 crore
4. Fairchem Organics Ltd ₹801 crore
5. [Shree Ganesh Remedies Ltd](https://www.sectoralpha.in/stocks/shree-ganesh-remedies-ltd) ₹792 crore
6. [Gem Aromatics Ltd](https://www.sectoralpha.in/stocks/gem-aromatics-ltd) ₹716 crore
7. [GFL Ltd](https://www.sectoralpha.in/stocks/gfl-ltd) ₹568 crore

[All 20 Chemicals - Organic companies, largest first](https://www.sectoralpha.in/sectors/chemicals-organic#all-companies)

### Companies close in size in other industries

1. [Metalic Technoforge Ltd](https://www.sectoralpha.in/stocks/metalic-technoforge-ltd) ₹805 crore · IT - Software
2. [Likhitha Infrastructure Ltd](https://www.sectoralpha.in/stocks/likhitha-infrastructure-ltd) ₹803 crore · Infra - Construction & Contracting
3. Fairchem Organics Ltd ₹801 crore
4. [RNFI Services Ltd](https://www.sectoralpha.in/stocks/rnfi-services-ltd) ₹800 crore · E-Commerce - Platform - Utility
5. [Manoj Vaibhav Gems N Jewellers Ltd](https://www.sectoralpha.in/stocks/manoj-vaibhav-gems-n-jewellers-ltd) ₹799 crore · Diamond, Gems & Jewellery

## What else do people ask about Fairchem Organics? ### What is Fairchem Organics's share price today? Fairchem Organics Ltd's share price is ₹681.45, −7.7% over the past year. The whole company is worth ₹858 Cr on the market. In the last 52 weeks it traded between ₹457 to ₹797; today it is 66% of the way up from the low, 0.6% below its 200-day average (as of 4 November 2026). ### What were Fairchem Organics's latest quarterly results? Fairchem Organics Ltd reported revenue of ₹167 Cr and net profit of ₹10.0 Cr for the Sep 2026 quarter. Revenue rose 49.1% and profit rose 900.0% compared with a year earlier. Earnings per share were ₹8.07. The operating margin was 10.0%, 6.2 percentage points higher than a year earlier (as of 4 November 2026). ### What is Fairchem Organics's market cap? Fairchem Organics Ltd's market capitalisation is ₹858 Cr at a share price of ₹681.45. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is Fairchem Organics performing? Fairchem Organics Ltd's share price has been stalling near its high for 4 weeks. In its latest quarter, revenue rose 49.1% and profit rose 900.0% compared with a year earlier. Over the past 13 weeks it has done worse than the NIFTY 500, for 2 weeks running (as of 4 November 2026). ### Will Fairchem Organics's share price go up? This page does not forecast Fairchem Organics Ltd's share price. What it shows instead: the share price is ₹681.45, and it has been stalling near its high for 4 weeks. Its P/E of 35.0× is higher than 38% of its own last 6 years (as of 4 November 2026). ### Who owns Fairchem Organics? Promoters own 63.3% of Fairchem Organics Ltd, foreign institutions 6.4%, domestic institutions 1.4% and the public 29.0% (latest quarter). The biggest change over the last two years: Domestic institutions cut their stake by 3.7 percentage points over 8 quarters (as of 4 November 2026). ### Does Fairchem Organics have too much debt? Fairchem Organics Ltd has a moderate amount of debt: its debt is 0.32× its equity, and its operating profit is 6 times its interest bill. FY26 borrowings were ₹84.0 Cr against equity of ₹263 Cr. Keep that borrowing in mind when reading the returns on this page (as of 4 November 2026). ### Where is Fairchem Organics in its business cycle? Fairchem Organics Ltd's FY26 operating margin was 4.7%, against a 7-year range of 4.7% to 17.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 10.0%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the Fairchem Organics story? The main question: the share price moved −7.7% in a year while yearly earnings per share moved −73.9%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Fairchem Organics a stock worth studying right now? What the numbers show: Fairchem Organics Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). This is research, not advice. We’re not SEBI-registered.